HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given a consensus rating of “Moderate Buy” by the fourteen brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $110.71.

Several research firms have recently issued reports on HQY. Royal Bank of Canada upped their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. BTIG Research increased their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Mizuho assumed coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. The Goldman Sachs Group started coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price on the stock. Finally, JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th.

Insider Buying and Selling

In other news, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This trade represents a 21.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at approximately $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,539 shares of company stock valued at $4,040,303 over the last quarter. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently made changes to their positions in HQY. Wasatch Advisors LP raised its position in HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after acquiring an additional 483,269 shares during the last quarter. Mackenzie Financial Corp raised its position in shares of HealthEquity by 16.0% during the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after purchasing an additional 325,906 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its position in shares of HealthEquity by 36.7% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after purchasing an additional 226,563 shares during the last quarter. Thrivent Financial for Lutherans lifted its stake in HealthEquity by 924.2% in the 2nd quarter. Thrivent Financial for Lutherans now owns 220,220 shares of the company’s stock valued at $18,983,000 after buying an additional 198,718 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in HealthEquity by 8.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,547,402 shares of the company’s stock valued at $133,377,000 after buying an additional 115,841 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

Shares of HQY stock opened at $97.47 on Friday. The company has a market cap of $8.45 billion, a P/E ratio of 89.42, a PEG ratio of 1.08 and a beta of 0.55. The firm has a fifty day moving average price of $96.88 and a 200 day moving average price of $85.47. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a 12 month low of $65.01 and a 12 month high of $105.82.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.